Skip to content

Clinical observation of objective optical quality after orthokeratology in myopia children

Clinical observation of objective optical quality after orthokeratology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036969
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

low,moderate and high myopia group:orthokeratology lenses
low,moderate and high myopia group:spectacle glass

Sponsors

Shanghai Eye Disease Prevention & Treatment Center /Shanghai Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. subjects aged 8–14 years; 2. had no other ocular diseases aside from refractive error and no keratoconus (confirmed by pre-treatment corneal topography); 3. had an intraocular pressure (IOP) of <21 mmHg; 4. had an with-the- rule astigmatism (axes 180+/-30) <= 1.50 D; 5. had a BCVA (best corrected visual acuity) <= 0.00 log MAR units in both eyes (Snellen equivalent to 20/20).

Exclusion criteria

Exclusion criteria: 1. had binocular vision problems; 2. use medications that might affect refractive development; 3. had history of ortho-k or contact lens wear; 4. Ocular surface diseases and other eye diseases which can cause abnormalities of ocular surface; 5. Patients with histories of ocular injury or surgery.

Design outcomes

Primary

MeasureTime frame
objective scatter index (OSI);

Secondary

MeasureTime frame
modulation transfer function (MTF) cutoff;Strehl ratio (SR);contrast visual acuity at 100%;contrast visual acuity at 20%;contrast visual acuity at 9%;axial length;peripheral refraction;IOP;Anterior corneal morphological characteristics;Posterior corneal morphological characteristics;HOAs;tear film quality;

Countries

China

Contacts

Public ContactMengjun Zhu

Shanghai Eye Disease Prevention & Treatment Center/Shanghai Eye Hospital

morning5012@163.com+86 13818102138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026